Primary hepatic leiomyosarcoma (PHL) is a rare malignant tumor, which originates from smooth muscles. Clinical presentation and imaging features are non-specific and can mimick the most frequent primary liver tumors namely hepatocellular carcinoma and intrahepatic cholangiocarcinoma. We report here two cases of PHL including one from the portal vein. The literature was searched for studies reporting cases of PHL reported from 2011 and 2019. The two patients were operated with R0 resection. Diagnosis of PHL was confirmed by histopathological and immunohistochemical examinations. Surgery remains the mainstay of the management of PHL. R0 resection is the main prognostic factor. Our literature search identified 16 additional cases from 12 reports. Preoperative diagnosis of PHL needs a high degree of suspicion due to atypical clinical presentation and non-specific imaging features. Surgery is the mainstay of the management of PHL. R0 resection is the main prognostic factor. (Ann Hepatobiliary Pancreat Surg 2020;24:63-67)
INTRODUCTION
Primary hepatic leiomyosarcomas (PHL) include 6-16% of the primary hepatic sarcomas which in turn represent 0.2-2% of primary hepatic cancers. 1 At MRI, the tumor was hyperintense and hypointense on T2-weighted and T1-weighted images, respectively. Peripheral contrast uptake was seen at arterial phase followed by reinforcement at the portal phase. The right portal vein could not be identified ( Fig. 2A, B ). Thoracic CT showed uneventful, and the patient was discharged home 24 days following surgery. The specimen weighed 5300 g and contained more than 1 L of hemorrhagic liquid (Fig. 2C, D) .
No tumor invasion was found in 5 lymph nodes, and the non-tumor liver parenchyma was normal. The tumor was not encapsulated, and no vascular invasion was found.
Immuno-histochemistry showed homogenous and diffuse staining for smooth muscle markers i.e., -smooth muscle actin, h-Caldesmone, and desmin. In addition, the tumor was negative for CD 34, cytokeratin CKAE1/AE3, C-Kit/ CD117, PS100, hepatocyte antigen, and Glypican-3. The proliferation index was estimated at 30% of tumor cells. 18 
DISCUSSION
Originating from smooth muscle, PHLs can arise from intrahepatic vascular structures, bile ducts or the round ligament. 6 The presence of a portal vein TT in our first case claims for a portal vein origin of the tumor. Among vascular leiomyosarcomas, those arising from portal vein are very rare and only five cases have been reported. 16, 17, [19] [20] [21] These cases are summarized in Table 1 . R0 resection could be performed in 4 out of 5 evaluable patients. Logically, hepatocellular carcinoma developed in healthy liver with portal vein TT is the first differential diagnosis for this type of PHL. Our first case was treated as so. 25 The following indirect arguments claim for a biliary origin of the second case: the round ligament and the vessels of the specimen were tumor free.
Diagnostic of PHL needs a high level of suspicion because clinical scenario, 6 and cross-imaging 11, 23 are not specific. Further, the absence of serological markers often delays diagnosis at the stage of large and/or metastatic tumor. 5 
